Delivery Order 36F79722D0178-19AQMM26F1521

<p>The Department of Administration issued a $68,964 delivery order to Sanofi Vaccines US Inc. on October 9, 2026, for 2026–2027 flu vaccine supply, with performance completion by October 9, 2027.</p> <p>The order is issued under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Swiftwater, PA. Pricing is firm fixed price with no set-aside applied.</p>

The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...

This is a firm fixed price delivery order awarded by the Department of State's Bureau of Administration to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of FLUARIX and FLULAVAL influenza vaccines. The order, valued at $544,388.00, was issued against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The vaccines are to be delivered to a location in Sterling, Virginia. The order was awarded without any set-aside designation on July 19, 2018, with a...

<p>The Department of Defense Medical Supply Chain issued a delivery order to Glaxosmithkline, LLC on October 28, 2015, with a ceiling value of $100,660 for influenza virus vaccine, with an ultimate completion date of November 30, 2015.</p> <p>Place of performance is Durham, NC 27709. The order is priced on a firm fixed price basis.</p>

<p>The Department of State Bureau of Administration awarded a $583,323 firm fixed price delivery order contract to Glaxosmithkline, LLC for 2023-2024 FLUARIX AND FLULAVAL VACCINE DELIVERY from August 14-18, 2023. Glaxosmithkline will provide influenza vaccines FLUARIX and FLULAVAL to the Department of State from its Sterling, Virginia location to support the agency's immunization program. No subcontractors were identified as participating on this contract action.</p>

This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...

This is a $148,256.00 firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC for the procurement of flu vaccines for fiscal year 2019. The delivery order has a completion date of March 31, 2019 and was awarded on March 15, 2019. There was no set-aside designation for this contract. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other pharmaceutical products to U.S....

This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC for the purchase of flu vaccines for the Huntington VA Medical Center. The $39,180.00 contract has an October 15, 2024 completion date and was awarded on March 21, 2024. There was no set-aside designation. Glaxosmithkline is a pharmaceutical company that provides various vaccines and medications to U.S. government agencies. They have previously...

The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Administration, awarded a delivery order valued at $133,372.10 to GlaxoSmithKline, LLC for the provision of vaccines for stock. The contract was awarded on October 17, 2016, with an ultimate completion date of October 25, 2016, and operates under a Firm Fixed Price structure with no set-aside designation. The award is issued as a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule...

This is a delivery order contract awarded by the Department of Health and Human Services to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. The $142,955.84 firm fixed price contract is not set aside and is made under Glaxosmithkline's General Services Administration Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. The delivery order supports the government's disease prevention and immunization efforts, with performance occurring at Glaxosmithkline's...